Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
1792983
Title:
ALPHA-L-IDURONIDASE RECOMBINANTE ET METHODES DE TRAITEMENT DES MALADIES CAUSEES PAR DES DEFICIENCES DE CELLE-CI
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
060115953
WO application number:
Type:
European patent granted for BE
Status:
Expired
Publication number:
1792983
WO publication number:
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:
Dates
Filing date:
09/11/2000
Grant date:
29/04/2009
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
17/07/2009
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
29/04/2009
EP B1 publication date:
29/04/2009
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
09/11/2020
Applicant
1
Name:
BioMarin Pharmaceutical Inc.
Legal Form:
From:
29/04/2009
Address:
105 Digital Drive, Novato CA 94949, United States (US)
To:
2
Name:
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Legal Form:
From:
29/04/2009
Address:
1124 West Carson Street, Torrance CA 90502, United States (US)
To:
Agent
1
Name:
NARGOLWALLA Cyra
Legal Form:
From:
22/04/2025
Address:
104, Rue de Richelieu
CS92104, 75080, PARIS Cedex 2, France (FR)
To:
2
Name:
NARGOLWALLA Cyra
Legal Form:
From:
17/07/2009
Address:
66, rue de la Chaussée d'Antin, 75440, PARIS CEDEX 9, France (FR)